Earnings Feed
Start Free
Coley Pharmaceutical Group, Inc.·4

Aug 17, 12:31 PM ET

Coley Pharmaceutical Group, Inc. 4

4 · Coley Pharmaceutical Group, Inc. · Filed Aug 17, 2005

Insider Transaction Report

Form 4
Period: 2005-08-16
Coley Pharmaceutical Group, Inc.COLY
Bratzler Robert L
DirectorPresident and CEO
Transactions
  • Conversion

    Common Stock

    2005-08-15+104,039→ 150,654 total(indirect: By Trust)
  • Conversion

    Common Stock

    2005-08-15+73,360→ 308,697 total
  • Conversion

    Series G Convertible Preferred Stock

    2005-08-15−476,500→ 0 total(indirect: By Trust)
    Exercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (104,039 underlying)
  • Conversion

    Series G Convertible Preferred Stock

    2005-08-15−335,993→ 0 total
    Exercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (73,360 underlying)
Footnotes (1)
  • [F1]The shares of Series G Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.

Documents

2 files